TAG:
clinical laboratories
Millennials’ Healthcare Demands Will Be Radically Different from Others
By Robert Michel | From the Volume XXVIII, No. 6 – May 3, 2021 Issue
This is an excerpt of a 1.620-word article in the May 3, 2021 issue of  THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: In just 42 months, Millennials will make up 75% of the workforce, according to U.S. Department of Co…
Millennials Set to Reorder Healthcare & Lab Testing
By Robert Michel | From the Volume XXVIII, No. 6 – May 3, 2021 Issue
CEO SUMMARY: In just 42 months, Millennials will make up 75% of the workforce, according to U.S. Department of Commerce statistics. As consumers and patients, they are already triggering changes, reforms, and innovation in healthcare. It is timely for clinical lab administrators and…
BioReference Labs to Use Gestalt for Digital Pathology
By Robert Michel | From the Volume XXVIII, No. 6 – May 3, 2021 Issue
ONE OF THE NATION’S LARGEST CLINICAL LABORATORIEScis moving forward with plans to expand its use of digital pathology and whole-slide imaging. On Mar. 30, it was announced that BioReference Laboratories, Inc. would move forward with Gestalt Diagnostics’ PathFlow digital pathology solu…
Lab Briefs
By Robert Michel | From the Volume XXVIII, No. 6 – May 3, 2021 Issue
Lighthouse Lab Services Acquires Vachette Pathology Last month, it was announced that Lighthouse Lab Services of Charlotte, N.C., had acquired Vachette Pathology of Sylvania, Ohio. Price and terms of the acquisition were not d…
UnitedHealthCare’s New Policy Further Narrows Its Lab Network
By Robert Michel | From the Volume XXVIII, No. 6 – May 3, 2021 Issue
UNITEDHEALTHCARE’S (UHC) RECENT MOVE to designate certain clinical and anatomic pathology laboratories as Designated Diagnostic Providers appears to be yet one more way that the insurer is narrowing its network. Effective July 1, 2021, and subject to st…
Lab Professions â€Haves,’ â€Have Nots,’ and Thieves
By R. Lewis Dark | From the Volume XXVIII No. 5 – April 12, 2021 Issue
ONCE AGAIN, THE LATEST NEWS OF IMPORTANCE in the clinical laboratory industry includes disparate topics that include legal/regulatory, new technology in anatomic pathology, fraud involving lab testing, and more consolidation in the in vitro diagnostics (IVD) industry….
Restitution and Guilty Plea in Two Lab Fraud Cases
By Robert Michel | From the Volume XXVIII No. 5 – April 12, 2021 Issue
CEO SUMMARY: In one case, owners and a sales rep agreed to pay restitution totaling almost $10 million. In the second case, three defendants pled guilty to federal charges involving payment or receipt of kickbacks and illegal inducements. A fourth defendent in this second case, a ph…
April 12, 2021 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXVIII No. 5 – April 12, 2021 Issue
One clinical laboratory company now says it provides COVID-19 testing services to all five of the major men’s professional sports leagues in the United States. On April 1, BioReference Laboratories, Inc. (BRLI), a division of Opko Health, announced a new agreement with Major League…
Revised Stark Law, Anti-Kickback Statute Rules Are Good News for Labs
By Robert Michel | From the Volume XXVIII, No. 4 – March 22, 2021 Issue
This is an excerpt of a 1,385-word article in the March 22, 2021 issue of  THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: The Dark Report explains how changes to the Stark Law and Anti-Kickback Statute will benefit labs,…
Despite COVID-19, Regular Lab Testing Expands
By R. Lewis Dark | From the Volume XXVIII, No. 4 – March 22, 2021 Issue
TIMES ARE GOOD FOR THE REGULAR RANGE of clinical laboratory and anatomic pathology testing services. Despite the COVID-19 pandemic, the daily number of routine test specimens is near pre-pandemic levels and certain sectors of lab testing—particularly genetic tests and some high-cost assays—are sh…
CURRENT ISSUE
Volume XXXI, No. 5 – April 8, 2024
The fragmentation of consumer markets is reflected in clinical lab services, and The Dark Report examines this trend and how it will impact labs in the coming years. Also, The Dark Report notes that the FDA has issued a controversial memo to reclassify many high-risk IVD assays.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized